vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and KFORCE INC (KFRC). Click either name above to swap in a different company.
KFORCE INC is the larger business by last-quarter revenue ($330.4M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). KFORCE INC runs the higher net margin — 2.4% vs 0.9%, a 1.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 0.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-7.4M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -3.7%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
FOLD vs KFRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $330.4M |
| Net Profit | $1.7M | $7.9M |
| Gross Margin | 85.7% | 27.3% |
| Operating Margin | 8.6% | 3.6% |
| Net Margin | 0.9% | 2.4% |
| Revenue YoY | 23.7% | 0.1% |
| Net Profit YoY | -88.5% | -2.7% |
| EPS (diluted) | $0.00 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $330.4M | ||
| Q4 25 | $185.2M | $332.0M | ||
| Q3 25 | $169.1M | $332.6M | ||
| Q2 25 | $154.7M | $334.3M | ||
| Q1 25 | $125.2M | $330.0M | ||
| Q4 24 | $149.7M | $343.8M | ||
| Q3 24 | $141.5M | $353.3M | ||
| Q2 24 | $126.7M | $356.3M |
| Q1 26 | — | $7.9M | ||
| Q4 25 | $1.7M | $5.2M | ||
| Q3 25 | $17.3M | $11.1M | ||
| Q2 25 | $-24.4M | $10.4M | ||
| Q1 25 | $-21.7M | $8.1M | ||
| Q4 24 | $14.7M | $11.1M | ||
| Q3 24 | $-6.7M | $14.2M | ||
| Q2 24 | $-15.7M | $14.2M |
| Q1 26 | — | 27.3% | ||
| Q4 25 | 85.7% | 27.2% | ||
| Q3 25 | 88.5% | 27.7% | ||
| Q2 25 | 90.2% | 27.1% | ||
| Q1 25 | 90.7% | 26.7% | ||
| Q4 24 | 90.1% | 27.0% | ||
| Q3 24 | 90.6% | 27.9% | ||
| Q2 24 | 91.1% | 27.8% |
| Q1 26 | — | 3.6% | ||
| Q4 25 | 8.6% | 2.6% | ||
| Q3 25 | 20.3% | 4.5% | ||
| Q2 25 | -6.1% | 4.5% | ||
| Q1 25 | -6.3% | 3.5% | ||
| Q4 24 | 10.7% | 4.5% | ||
| Q3 24 | 15.3% | 5.3% | ||
| Q2 24 | 11.8% | 5.5% |
| Q1 26 | — | 2.4% | ||
| Q4 25 | 0.9% | 1.6% | ||
| Q3 25 | 10.2% | 3.3% | ||
| Q2 25 | -15.8% | 3.1% | ||
| Q1 25 | -17.3% | 2.5% | ||
| Q4 24 | 9.8% | 3.2% | ||
| Q3 24 | -4.8% | 4.0% | ||
| Q2 24 | -12.4% | 4.0% |
| Q1 26 | — | $0.46 | ||
| Q4 25 | $0.00 | $0.29 | ||
| Q3 25 | $0.06 | $0.63 | ||
| Q2 25 | $-0.08 | $0.59 | ||
| Q1 25 | $-0.07 | $0.45 | ||
| Q4 24 | $0.05 | $0.60 | ||
| Q3 24 | $-0.02 | $0.75 | ||
| Q2 24 | $-0.05 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $1.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $117.4M |
| Total Assets | $949.9M | $384.8M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $293.5M | $2.1M | ||
| Q3 25 | $263.8M | $1.3M | ||
| Q2 25 | $231.0M | $2.5M | ||
| Q1 25 | $250.6M | $444.0K | ||
| Q4 24 | $249.9M | $349.0K | ||
| Q3 24 | $249.8M | $127.0K | ||
| Q2 24 | $260.1M | $110.0K |
| Q1 26 | — | — | ||
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | $117.4M | ||
| Q4 25 | $274.2M | $124.6M | ||
| Q3 25 | $230.4M | $132.1M | ||
| Q2 25 | $204.3M | $134.4M | ||
| Q1 25 | $193.6M | $138.0M | ||
| Q4 24 | $194.0M | $154.6M | ||
| Q3 24 | $178.8M | $167.4M | ||
| Q2 24 | $132.5M | $166.6M |
| Q1 26 | — | $384.8M | ||
| Q4 25 | $949.9M | $365.6M | ||
| Q3 25 | $868.8M | $374.2M | ||
| Q2 25 | $815.3M | $373.6M | ||
| Q1 25 | $789.8M | $368.2M | ||
| Q4 24 | $785.0M | $357.8M | ||
| Q3 24 | $786.6M | $369.9M | ||
| Q2 24 | $749.5M | $362.7M |
| Q1 26 | — | — | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | $-7.4M |
| FCF MarginFCF / Revenue | 8.6% | -2.2% |
| Capex IntensityCapex / Revenue | 0.2% | 1.0% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $19.7M | ||
| Q3 25 | $35.7M | $23.3M | ||
| Q2 25 | $-26.5M | $18.4M | ||
| Q1 25 | $7.8M | $249.0K | ||
| Q4 24 | $-3.9M | $21.8M | ||
| Q3 24 | $-23.0M | $31.0M | ||
| Q2 24 | $22.7M | $20.9M |
| Q1 26 | — | $-7.4M | ||
| Q4 25 | $16.0M | $16.7M | ||
| Q3 25 | $35.3M | $19.8M | ||
| Q2 25 | $-28.9M | $14.2M | ||
| Q1 25 | $7.5M | $-3.9M | ||
| Q4 24 | $-4.2M | $20.9M | ||
| Q3 24 | $-23.3M | $27.5M | ||
| Q2 24 | $21.6M | $17.8M |
| Q1 26 | — | -2.2% | ||
| Q4 25 | 8.6% | 5.0% | ||
| Q3 25 | 20.9% | 6.0% | ||
| Q2 25 | -18.7% | 4.3% | ||
| Q1 25 | 6.0% | -1.2% | ||
| Q4 24 | -2.8% | 6.1% | ||
| Q3 24 | -16.5% | 7.8% | ||
| Q2 24 | 17.0% | 5.0% |
| Q1 26 | — | 1.0% | ||
| Q4 25 | 0.2% | 0.9% | ||
| Q3 25 | 0.2% | 1.1% | ||
| Q2 25 | 1.6% | 1.2% | ||
| Q1 25 | 0.2% | 1.3% | ||
| Q4 24 | 0.2% | 0.3% | ||
| Q3 24 | 0.3% | 1.0% | ||
| Q2 24 | 0.9% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | 3.82× | ||
| Q3 25 | 2.06× | 2.11× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | -0.27× | 1.97× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 1.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
KFRC
Segment breakdown not available.
